This is a very valid point on Craig Ballistics, which is performing well operationally and is profitable. This should be low-hanging fruit as a product (or range of products) which would benefit from the inclusion BNNT. PPK would thereby demonstrate to the market an actual market-based (i.e. commercial) use for BNNT. Importantly, it could then show this to potential third-party purchasers the benefits of BNNT in commercial practice.
This is something PPK should seek to move fast on. The focus should be less on the science and size of end-use markets, and rather on the commercial, profitable uses of the science directly upon PPK. PPK should remove the word "science" from its vocabulary and substitute the word "profit".
This is a very valid point on Craig Ballistics, which is...
Add PPK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
0.100(23.3%) |
Mkt cap ! $47.32M | |||
| Open | High | Low | Value | Volume |
| 73.5¢ | 76.0¢ | 52.5¢ | $1.137M | 1.891M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 42278 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 1705 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
53.5¢ |
Change
0.100 ( 25.9 %) |
||||
| Open | High | Low | Volume | ||
| 75.0¢ | 75.0¢ | 53.5¢ | 188072 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| PPK (ASX) Chart |